Publications by authors named "Yannick Beausejour"

Claim this Profile
L
Lymphopenia as a novel marker of Clostridium difficile infection recurrence.
Valéry Lavergne, Yannick Beauséjour, Gilbert Pichette, Marc Ghannoum, Shih Hann Su

J Infect· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution inflammatory syndrome following cryptosporidial cholangitis.
Yannick Beauséjour, Claude Fortin, Marc Ghannoum, Valéry Lavergne

AIDS· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.
Yannick Beauséjour, Fernando Alvarez, Martin Beaulieu, Marc Bilodeau

Can J Gastroenterol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
Geneviève Martin, Yannick Beauséjour, Jacques Thibodeau, Michel J Tremblay

Virology· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.
Yannick Beauséjour, Michel J Tremblay

J Virol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.
Jean-François Fortin, Corinne Barat, Yannick Beauséjour, Benoit Barbeau, Michel J Tremblay

J Biol Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane.
Yannick Beauséjour, Michel J Tremblay

J Infect Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
Yannick Beauséjour, Michel J Tremblay

Virology· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis